Non-specific immunomodulation in chronic heart failure

The Lancet

Volumn 371, Issue 9630, 2008, Pages 2083-

  Fildes, James E ^a   Shaw, Steven M ^a   Yonan, Nizar ^a   Williams, Simon G ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOLOGIC FACTOR;

APOPTOSIS; CELL STRESS; CYTOKINE RELEASE; HEART FAILURE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; INFLAMMATION; LETTER; MEDICAL RESEARCH; OXIDATIVE STRESS; PRIORITY JOURNAL; BIOSYNTHESIS; CHRONIC DISEASE; HUMAN; IMMUNOLOGY; NOTE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

APOPTOSIS; CHRONIC DISEASE; CYTOKINES; HEART FAILURE; HUMANS; IMMUNOLOGIC FACTORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 45249098915     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60913-7     Document Type: Letter

References (5)

1. Torre-Amione G., Anker S., Bourge R., et al. Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial. Lancet 371 (2008) 228-236
2. Boehme S., and Lenardo M. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur J Immunol 23 (1993) 1552-1560
3. Zheng L., Fisher G., Miller R., et al. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377 (1995) 348-351
4. Jones L., Chin L., Longo D., et al. Peripheral clonal elimination of functional T cells (1990). Science 250 (1990) 1726-1729
5. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 12 (1994) 991-1045